New Definition of Epilepsy Improves Diagnosis, Treatment
By Lori Solomon HealthDay Reporter
TUESDAY, April 15, 2025 -- The new International League Against Epilepsy (ILAE) definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment, according to a study published online March 23 in Frontiers in Neurology.
Lena Habermehl, M.D., from the Epilepsy Center Hessen at Philipps-University Marburg in Germany, and colleagues investigated the clinical impact of the new ILAE epilepsy definition on diagnosis, treatment, and short-term outcome. The analysis included 235 adult patients admitted with a first epileptic seizure from 2018 to 2021.
The researchers found that 62.1 percent of patients were diagnosed with epilepsy, following the new ILAE criteria. Just under half of people diagnosed with epilepsy had potential epileptogenic lesions on imaging (49.3 percent). At six months of follow-up, three-quarters of patients were seizure-free (77.3 percent), including 89 of the 146 patients diagnosed with epilepsy (70.6 percent). At 12 months of follow-up, 129 patients (80.6 percent) were seizure-free. The use of antiseizure medicine significantly decreased the recurrence rate (odds ratio, 0.46).
"Our results suggest that the new definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment," the authors write. "Short-term outcomes improved (one-year recurrence rate of 19.4 percent)."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.